Is Johnson & Johnson (JNJ) a buy today?
Johnson & Johnson currently carries an AI verdict of under review. Use that as a research starting point alongside price structure, risk score, and live news rather than as financial advice.
Our AI Committee has evaluated Johnson & Johnson (JNJ) and currently issues a Neutral verdict. The 14-day RSI currently reads 34.2, indicating a neutral momentum regime with room to trend in either direction.
Macro Desk — Global Picture & Capital Flows
System Summary: Average signals. Needs more volume to confirm trend. ⏳
Quant Desk — Algorithmic & Technical Signals
Technicals (Weak Momentum): Vol Surge
Fundamental Desk — Valuation & Financial Health
Fundamentals: Delivery Avg Delivery, Debt: Moderate Debt
This analysis is generated by MicroStocks' multi-agent AI committee and is refreshed every hour. Learn how our AI generates these verdicts →
AI Market Briefing
P/E Ratio
26.4x
50-Day SMA
$240.23
Beta
0.33
Market Cap
$547.6B
Johnson & Johnson currently carries an AI verdict of under review. Use that as a research starting point alongside price structure, risk score, and live news rather than as financial advice.
A live Micro-Score is not available for JNJ right now, but the page still tracks its verdict, risk profile, and market action.
The live technical stack on this page tracks RSI at 34.2, the 20-day moving average at $237.08, and the 50-day moving average at $240.23 to frame momentum and trend alignment.
Canonical: https://www.microstocks.in/stock/JNJ
Our AI Committee currently assigns a Neutral verdict for Johnson & Johnson. The 14-day RSI stands at 34.2, placing it in a neutral momentum regime.
AI Committee analysis is currently being computed for JNJ. Check back shortly.